Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD
Clinical trial NCT07357532 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07357532
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-31
- Primary completion
- 2028-09-26
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.